| [1] |
. FEBS J，2021，288（14）：4291-4310.
|
| [2] |
Aghamiri S，Zandsalimi F，Raee P，et al. Antimicrobial peptides as potential therapeutics for breast cancer［J］. Pharmacol Res，2021，171：105777.
|
| [3] |
Zhu YQ，Feijen J，Zhong ZY. Dual-targeted nanomedicines for enhanced tumor treatment［J］. Nano Today，2018，18：65-85.
|
| [4] |
Tavianatou AG，Piperigkou Z，Barbera C，et al. Molecular size-dependent specificity of hyaluronan on functional properties，morphology and matrix composition of mammary cancer cells［J］. Matrix Biol Plus，2019，3：100008.
|
| [5] |
Cai J，Fu JR，Li RR，et al. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles［J］. Carbohydr Polym，2019，208：356-364.
|
| [6] |
Matricardi P，di Meo C，Coviello T，et al. Interpenetrating Polymer Networks polysaccharide hydrogels for drug delivery and tissue engineering［J］. Adv Drug Deliv Rev，2013，65（9）：1172-1187.
|
| [7] |
Dzobo K，Sinkala M. Cancer stem cell marker CD44 plays multiple key roles in human cancers：immune suppression/evasion，drug resistance，epithelial-mesenchymal transition，and metastasis［J］. OMICS，2021，25（5）：313-332.
|
| [8] |
Zhang YB，Li Y，Tian HN，et al. Redox-responsive and dual-targeting hyaluronic acid-methotrexate prodrug self-assembling nanoparticles for enhancing intracellular drug self-delivery［J］. Mol Pharm，2019，16（7）：3133-3144.
|
| [9] |
Ashrafizadeh M，Mirzaei S，Gholami MH，et al. Hyaluronic acid-based nanoplatforms for Doxorubicin：a review of stimuli-responsive carriers，co-delivery and resistance suppression［J］. Carbohydr Polym，2021，272：118491.
|
| [10] |
Cui H，Huan ML，Ye WL，et al. Mitochondria and nucleus dual delivery system to overcome DOX resistance［J］. Mol Pharm，2017，14（3）：746-756.
|
| [11] |
Popescu RC，Savu DI，Bierbaum M，et al. Intracellular delivery of doxorubicin by iron oxide-based nano-constructs increases clonogenic inactivation of ionizing radiation in HeLa cells［J］. Int J Mol Sci，2021，22（13）：6778.
|
| [12] |
Hou WX，Zhao X，Qian XQ，et al. pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy［J］. Nanoscale，2016，8（1）：104-116.
|
| [13] |
Phua SZF，Yang GB，Lim WQ，et al. Catalase-integrated hyaluronic acid as nanocarriers for enhanced photodynamic therapy in solid tumor［J］. ACS Nano，2019，13（4）：4742-4751.
|
| [14] |
Feng L，Chen MY，Li RH，et al. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/photodynamic therapy［J］. Acta Biomater，2022，138：463-477.
|
| [15] |
Li SP，Sun ZH，Deng GJ，et al. Dual-modal imaging-guided highly efficient photothermal therapy using heptamethine cyanine-conjugated hyaluronic acid micelles［J］. Biomater Sci，2017，5（6）：1122-1129.
|
| [16] |
Cai Y，Si WL，Huang W，et al. Organic dye based nanoparticles for cancer phototheranostics［J］. Small，2018，14（25）：e1704247.
|
| [17] |
Wang SJ，Tang QQ，Ya HY，et al. Study on the optical and biological properties in vitro of IR808‐PEG‐FA［J］. J Biomed Mater Res，2020，108（9）：1816-1823.
|
| [18] |
Leit?o MM，de Melo-Diogo D，Alves CG，et al. Prototypic heptamethine cyanine incorporating nanomaterials for cancer phototheragnostic［J］. Adv Healthc Mater，2020，9（6）：e1901665.
|
| [19] |
Liu SS，Song RX，Li XS，et al. Synergistic therapeutic strategies for cancer treatment based on nanophototherapy［J］. Nanophotonics，2021，10（12）：3391-3395.
|
| [20] |
Góth L. A simple method for determination of serum catalase activity and revision of reference range［J］. Clin Chim Acta，1991，196（2/3）：143-151.
|
| [21] |
Cheng X，He L，Xu JX，et al. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy［J］. Acta Biomater，2020，112：234-249.
|
百度学术
下载:
